| RS2541884578 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541885429 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541885548 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2541885885 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541886499 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS2541887517 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541887540 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541887724 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541888049 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541889602 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2541891322 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS2541891452 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541893689 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541897696 |
SMAD6
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2541898218 |
SMAD6
|
Health Risk |
Likely pathogenic |
— |
| RS2541899899 |
SGCG
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2541899936 |
SGCG
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2541900116 |
SMAD6
|
Health Risk |
Likely pathogenic |
Aortic valve disease 2, Aortic valve disease 2 |
| RS2541900238 |
SGCG
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2541900264 |
SGCG
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2541900385 |
SGCG
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2541902277 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541903490 |
POLE
|
Health Risk |
Likely pathogenic |
POLE-related disorder, POLE-related disorder |
| RS2541910203 |
VPS13C
|
Health Risk |
Pathogenic |
— |
| RS2541927522 |
FANCC
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2541932405 |
FANCC
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia, Fanconi anemia |
| RS2541936326 |
SGCG
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2541936647 |
SGCG
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2541936716 |
SGCG
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2541940200 |
SPTAN1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2541941372 |
SPTAN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder, Neurodevelopmental disorder |
| RS2541942149 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541944514 |
CEP164
|
Health Risk |
Pathogenic |
Nephronophthisis 15, Nephronophthisis 15 |
| RS2541948100 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541949935 |
PCCA
|
Health Risk |
Pathogenic/Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2541950774 |
FANCC
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group C, Fanconi anemia complementation group C |
| RS2541951597 |
PCCA
|
Health Risk |
Pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2541951817 |
SPTAN1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS2541952847 |
SPTAN1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 5 |
| RS2541953292 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541953376 |
PCCA
|
Health Risk |
Likely pathogenic |
Propionic acidemia, Propionic acidemia |
| RS2541953524 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2541954580 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541955127 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2541955334 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541955840 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541965807 |
RORA
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, Intellectual developmental disorder with or without epilepsy or cerebellar ataxia |
| RS2541966112 |
RORA
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, Intellectual developmental disorder with or without epilepsy or cerebellar ataxia |
| RS2541973548 |
POLR3B
|
Health Risk |
Likely pathogenic |
— |
| RS2541974207 |
RORA
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2541982138 |
CEP164
|
Health Risk |
Pathogenic/Likely pathogenic |
CEP164-related disorder, Nephronophthisis 15 |
| RS2541983871 |
GATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS2541984182 |
GATM
|
Health Risk |
Pathogenic |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS2541984266 |
GATM
|
Health Risk |
Likely pathogenic |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS2541986290 |
GATM
|
Health Risk |
Likely pathogenic |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS2541989303 |
GATM
|
Health Risk |
Likely pathogenic |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS2541994504 |
RORA
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, Intellectual developmental disorder with or without epilepsy or cerebellar ataxia |
| RS2541994594 |
GATM
|
Health Risk |
Likely pathogenic |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS2541995490 |
ADSS1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2541997209 |
SGCG
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2541998068 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541998509 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541998903 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2541998982 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2541998998 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542002104 |
POLE
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2542002493 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542005145 |
GATM
|
Health Risk |
Likely pathogenic |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS2542006088 |
GATM
|
Health Risk |
Likely pathogenic |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS2542007172 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS2542007203 |
POLE
|
Health Risk |
Likely pathogenic |
— |
| RS2542007430 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542007724 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542008543 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542009211 |
POLE
|
Health Risk |
Likely pathogenic |
POLE-related disorder, POLE-related disorder |
| RS2542009773 |
GATM
|
Health Risk |
Likely pathogenic |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS2542009946 |
GATM
|
Health Risk |
Pathogenic |
Arginine:glycine amidinotransferase deficiency, Arginine:glycine amidinotransferase deficiency |
| RS2542022431 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542022469 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542026550 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542029970 |
SGCG
|
Health Risk |
Pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2C, Autosomal recessive limb-girdle muscular dystrophy type 2C |
| RS2542037480 |
KSR2
|
Health Risk |
Likely pathogenic |
KSR2-related disorder, KSR2-related disorder |
| RS2542040039 |
ADSS1
|
Health Risk |
Pathogenic |
— |
| RS2542040863 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542046126 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542046751 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542046843 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542049088 |
RORA
|
Health Risk |
Likely pathogenic |
Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, Intellectual developmental disorder with or without epilepsy or cerebellar ataxia |
| RS2542049491 |
ADSS1
|
Health Risk |
Pathogenic |
— |
| RS2542051635 |
RORA
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, Intellectual developmental disorder with or without epilepsy or cerebellar ataxia |
| RS2542051691 |
RORA
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, Intellectual developmental disorder with or without epilepsy or cerebellar ataxia |
| RS2542052131 |
RORA
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, Intellectual developmental disorder with or without epilepsy or cerebellar ataxia |
| RS2542061584 |
KSR2
|
Health Risk |
Likely pathogenic |
KSR2-related disorder, KSR2-related disorder |
| RS2542062300 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542062750 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542066600 |
POLE
|
Health Risk |
Pathogenic |
Myoepithelial tumor, Myoepithelial tumor |
| RS2542073001 |
RORA
|
Health Risk |
Pathogenic |
Intellectual developmental disorder with or without epilepsy or cerebellar ataxia, Intellectual developmental disorder with or without epilepsy or cerebellar ataxia |
| RS2542073242 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542073442 |
POLE
|
Health Risk |
Pathogenic |
— |
| RS2542073597 |
POLR3B
|
Health Risk |
Likely pathogenic |
Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism, Hypomyelinating leukodystrophy 8 with or without oligodontia and-or hypogonadotropic hypogonadism |